ASTeCC Incubator Companies
Advanced Semiconductor Processing Technology
Zhi David Chen
Based on research by Zhi David Chen, Center for Nanoscale Science & Engineering
Advanced Semiconductor Processing Technology’s current product is a dew point sensor which is based upon research on semiconductor processing technology and its applications on electronic devices including sensors and transistors. The company has also developed a new type of moisture sensor called alpha-Al2O3 based dew point.
Biomedical Development Corporation
BrainChem
Peter Huettl
Based on research from the Center for Microelectrode Technology, Greg Gerhardt director, Peter Huettl assistant director
Developing a new generation of clinical diagnostic devices for patients with epilepsy and traumatic brain injury.
Brockman Hastings
Todd Hastings, CEO, 859.576.4951
DermVantage
Dr. Sybille Muller, 859.533.7287
DermVantage is developing transfollicular delivery of biological agents for the cosmetic and medical industries. The company is exploring using its technology to treat hyperhidrosis and cancer.
Exatherm
Scott Merz
Exatherm is developing a medical device that can apply heat to localized areas on patients to treat lung, colon, pancreatic and other forms of cancer. The process has been shown to selectively kill cancer cells and enhance the effects of certain chemotherapy drugs without damaging normal tissues. The company is planning a clinical trial with lung cancer patients at the University of Kentucky in late 2012 with a novel whole body circulatory hyperthermia system.
Invenio Therapeutics
Mukesh Agarwal, President, 216.496.9053
Invenio Therapeutics Inc. is an early-stage biopharmaceutical company developing novel drug compounds that terminally differentiate leukemia cells so that they no longer have the ability to divide and replicate. Invenio's focus is R&D on cutting-edge drug treatments targeting Acute Myeloid Leukemia (AML), for which no cure exists.
Kentucky Space
Kris Kimel and Mahendra Jain
Kentucky Space involves select Kentucky universities, including UK and Morehead State University, focused on small entrepreneurial and educational space solutions. Kentucky Space is owned by the Kentucky Science &Technology Corporation.
MiRX Pharmaceutical LLC
Minerva Systems & Technologies
Kalyan Ganesan, Chief Technology Officer, 859.489.0156 or 859.218.6569
Minerva Systems & Technologies, LLC is an emerging technology company with expertise in navigation and guidance, satellite & wireless communications, signal processing, and embedded hardware and software design and development.
Nano-Mite Technologies
Based on research by Patrick Sullivan / SCoBIRC and anatomy & neurobiology
R&D to control obesity using nanotechnology to alter the body's metabolic rate and increase the cell's ability to convert sugar to energy. Research could lead to future breakthroughs in the treatment of traumatic central nervous system damage and neurodegenerative disorders.
Naprogenix
Based on research by John Littleton / molecular pharmacology and plant genomics
Commercialized technology that enables bio-prospecting (screening) of Kentucky native plants and mutant plants for molecules that could lead to plant-based medicines and natural insecticides. Founded in 2002, the company's current focus is on non-toxic insecticides, CNS-acting drugs and chemotherapeutic agents.
PureLight Labs
Steve Mullane
PureLight Labs is a leading supplier of an innovative, high performing and cost effective liquid high-refractive index technology platform designed to improve the capture of light. Their unique liquid thin film technology provides a significant competitive advantage by offering a highly differentiated approach to the standard chemical vapor deposition processes, and emerging high cost and unstable nanoparticle technology formulations. PureLight Labs' technology is demonstrating best in class results in both optical performance and stability.
Scout Diagnostics
Based on research by founding scientists Mark Lovell and Bert Lynn / chemistry and the Sanders-Brown Center on Aging
Scout Diagnostics was founded in 2006 to develop and market a new early diagnostic test for Alzheimer's disease. The testing kit will identify certain protein complexes in cerebral spinal fluid which serve as biomarkers to detect Alzheimer's prior to clinical diagnosis. In addition to their faculty appointments in the chemistry department, co-founder Mark Lovell is affiliated with the Sanders-Brown Center on Aging and has a joint appointment in the College of Medicine and Bert Lynn is the director of the UK Mass Spectrometry Center.
Seikowave
Based on research by Daniel Lau / Center for Visualization & Virtual Environments
Matt Bellis
Seikowave is developing three dimensional imaging technologies targeted at medical, security and industrial imaging applications. Seikowave's patent-pending optical architectures combined with Daniel Lau's (UK Center for Visualization & Virtual Environments) patent-pending machine vision algorithms enable high performance, low cost 3D imaging solutions capable of capturing human motion in real time. Seikowave, with offices in the U.S. and Japan, is working with global healthcare, security and semiconductor companies to bring these imaging solutions to market.
Vindico NanoBioTechnology
Eric Ostertag, 859.218.6568
Vindico applies proprietary polymersome technology to develop and commercialize diagnostic and therapeutic applications focusing on the transfusion medicine market.
W-Z Biotech
Cherry Croft
W-Z Biotech, founded in 2009 by Dr. Jay Zwischenberger, surgery, and Dr. Dongfang Wang, cardiothoracic surgery, specializes in the development of novel medical devices for cardiopulmonary surgery and hyperthermia delivery systems for lung cancer therapy.
Contact
-
ASTeCC leasing director
Tanya Floyd 859.218.6563 -
ASTeCC operations coordinator
Larry Farmer 859.218.6519




connect with us